Both in Biotechnology
Novavax vs Vir Biotechnology
Over the past year NVAX returned +26.3% and VIR returned +89.2%; their daily moves had a correlation of 0.38.
NVAX +26.3% VIR +89.2%Growth of $1, one year, split-adjusted
| Metric | NVAX | VIR |
|---|---|---|
| Price | $10.82 | $10.65 |
| Market cap | $1.78B | $1.80B |
| Today | +0.19% | +1.33% |
| 1 month | +16.8% | −1.7% |
| 6 months | +33.7% | +25.9% |
| Year to date | +61.0% | +76.6% |
| 1 year | +26.5% | +94.0% |
| Revenue growth (YoY) | −76.3% | +19582.5% |
| Gross margin | 74.9% | 100.0% |
| Net margin | −94.2% | 33.5% |
| P/E (TTM) | — | — |
| Price / sales | 4.3× | 5.9× |
| Net cash | $422.0M | $532.7M |
| Dividend yield | — | — |
| Volatility (60d) | 49.2% | 46.1% |
| Short % of float | 31.9% | 14.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).